3M
MIT, 3M Receive $500K to Develop Rapid SARS-CoV-2 Antigen Diagnostic Test
The test was selected for accelerated development and commercialization support by the NIH through the RADx Tech program for COVID-19 diagnostics.
The test was selected for accelerated development and commercialization support by the NIH through the RADx Tech program for COVID-19 diagnostics.